Pharma sales reps should couple product information with detailing features during in-person meetings to better engage the HCPs and ensure script lift.
Questions answered in this report:
- How many US physicians are actually prescribing the drugs dicussed in the rep meetings?
- What information & services discussed during the meetings influence HCPs’ prescribing decisions?
- To what extent each of these information & services influence scripting?
- How can the pharma reps use them to make the in-person meetings more impactful on scripts?